Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Ann Surg
    November 2024
  1. SIHAG S
    Real-world Application of Endoscopic Resection for Early-stage Esophageal Cancer: do we need to rethink the guidelines?
    Ann Surg. 2024 Nov 20. doi: 10.1097/SLA.0000000000006593.
    >> Share

  2. PUCCETTI F, Cinelli L, Barbieri LA, Socci D, et al
    The Near-Infrared Visualization and Preemptive Ligation of the Thoracic Duct Effectively Reduce the Chyle Leak Incidence After Minimally Invasive Esophagectomy.
    Ann Surg. 2024;280:780-787.
    >> Share

  3. WIRSIK NM, Kooij CD, Dempster N, Crnovrsanin N, et al
    Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2024;280:799-807.
    >> Share

    October 2024
  4. MARKAR SR, Sgromo B, Evans R, Griffiths EA, et al
    The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE Study.
    Ann Surg. 2024;280:650-658.
    >> Share

    September 2024
  5. PUCHER PH, Rahman SA, Bhandari P, Blencowe N, et al
    Prevalence and Risk Factors for Malignant Nodal Involvement in Early esophago-gastric Adenocarcinoma: Results from the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy For Early Esophagogastric Cancers).
    Ann Surg. 2024 Sep 2. doi: 10.1097/SLA.0000000000006496.
    >> Share

    August 2024
  6. DONLON NE, Moran B, Davern M, Davey MG, et al
    Evidence for the Positive Impact of Centralization in Esophageal Cancer Surgery.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006487.
    >> Share

  7. OVERTOOM HCG, Eyck BM, van der Wilk BJ, Noordman BJ, et al
    Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006488.
    >> Share

  8. WANG J, de Jongh C, Wu Z, de Groot EM, et al
    Impact of Preoperative Time Intervals for Neoadjuvant Chemoradiotherapy on Short-term Postoperative Outcomes of Esophageal Cancer Surgery: A Population-Based Study Using the Dutch Upper Gastrointestinal Cancer Audit (DUCA) Data.
    Ann Surg. 2024 Aug 8. doi: 10.1097/SLA.0000000000006476.
    >> Share

    July 2024
  9. DEBOEVER N, Correa AM, Feldman H, Eisenberg M, et al
    Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival.
    Ann Surg. 2024;280:91-97.
    >> Share

    April 2024
  10. HENCKENS SP, Schuring N, Elliott JA, Johar A, et al
    Recurrence and Survival after Minimally Invasive and Open Esophagectomy for Esophageal Cancer - A Post Hoc Analysis of the Ensure Study.
    Ann Surg. 2024 Apr 5. doi: 10.1097/SLA.0000000000006280.
    >> Share

    March 2024
  11. AIOLFI A, Bona D, Bonitta G, Bonavina L, et al
    Short-term Outcomes of Different Techniques for Gastric Ischemic Preconditioning Before Esophagectomy: A Network Meta-analysis.
    Ann Surg. 2024;279:410-418.
    >> Share

    January 2024
  12. PARK SY, Park B, Yun JK, Kim HR, et al
    Proposal of New ypStage Grouping System for Esophageal Squamous Cell Carcinoma Patients who Underwent Neoadjuvant Chemoradiotherapy followed by Surgery.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006204.
    >> Share

    December 2023
  13. KARALIS JD, Ju MR, Yoon LY, Castro-Dubon EC, et al
    Serum Interleukin 6 Level is Associated With Overall Survival and Treatment Response in Gastric and Gastroesophageal Junction Cancer.
    Ann Surg. 2023;278:918-924.
    >> Share

  14. OWEN RP, Chidambaram S, Griffiths EA, Sultan J, et al
    Multicenter, Prospective Cohort Study of Oesophageal Injuries and Related Clinical Outcomes (MUSOIC study).
    Ann Surg. 2023;278:910-917.
    >> Share

    November 2023
  15. WIRSIK NM, Schmidt T, Nienhuser H, Donlon NE, et al
    Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2023;278:683-691.
    >> Share

  16. VEZIANT J, Boudis F, Lenne X, Bruandet A, et al
    Outcomes Associated With Esophageal Perforation Management: Results From a French Nationwide Population-based Cohort Study.
    Ann Surg. 2023;278:709-716.
    >> Share

  17. ELLIOTT JA, Klevebro F, Mantziari S, Markar SR, et al
    Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
    Ann Surg. 2023;278:692-700.
    >> Share

  18. HWANG H, Choi JY, Yu HW, Moon JH, et al
    Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
    Ann Surg. 2023;278:e1087-e1095.
    >> Share

    September 2023
  19. COWZER D, Wu AJ, Sihag S, Walch HS, et al
    Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.
    Ann Surg. 2023;278:e511-e518.
    >> Share

    July 2023
  20. CHIDAMBARAM S, Owen R, Sgromo B, Chmura M, et al
    Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006028.
    >> Share

  21. ALTORKI N, Mynard N, Nasar A, Spinelli C, et al
    Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus.
    Ann Surg. 2023;278:e43-e50.
    >> Share

    June 2023
  22. GUJJURI RR, Clarke JM, Elliott JA, Rahman SA, et al
    Predicting long-term survival and time-to-recurrence after esophagectomy in patients with esophageal cancer - Development and validation of a multivariate prediction model.
    Ann Surg. 2023;277:971-978.
    >> Share


  23. Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study: Erratum.
    Ann Surg. 2023;277:e1397.
    >> Share

    May 2023
  24. BOERNER T, Harrington C, Tan KS, Adusumilli PS, et al
    Waiting to Operate: The Risk of Salvage Esophagectomy.
    Ann Surg. 2023;277:781-788.
    >> Share

  25. YAN L, Liu Y, Li W, Zhu Y, et al
    Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
    Ann Surg. 2023;277:846-853.
    >> Share

  26. BAYLEY EM, Ivy ML, Shewale JB, Ge PS, et al
    High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.
    Ann Surg. 2023;277:721-726.
    >> Share


  27. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).
    Ann Surg. 2023;277:e1026-e1034.
    >> Share

    April 2023
  28. KALFF MC, van Berge Henegouwen MI, Baas PC, Bahadoer RR, et al
    Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care: The Dutch Nationwide Ivory Study.
    Ann Surg. 2023;277:619-628.
    >> Share

    March 2023
  29. REZA JA, Raman V, Vekstein A, Grau-Sepulveda M, et al
    Implementation of Screening Guidelines in Early Esophageal Cancer: A Study of the Society of Thoracic Surgeons General Thoracic Surgery Database.
    Ann Surg. 2023 Mar 13. doi: 10.1097/SLA.0000000000005837.
    >> Share

  30. SACHIDANANDA S, Timsina L, Namburi N, Birdas TJ, et al
    Esophagectomy Complications Impact Long-term Survival: A National Cancer Database Analysis.
    Ann Surg. 2023;277:437-441.
    >> Share

    February 2023
  31. ELY S, Alabaster A, Dominguez DA, Maxim C, et al
    Effect of Thoracic Surgery Regionalization on 1- and 3-Year Survival after Cancer Esophagectomy.
    Ann Surg. 2023;277:e305-e312.
    >> Share

  32. RAHMAN SA, Walker RC, Maynard N, Nigel Trudgill, et al
    The AUGIS Survival Predictor: Prediction of Long-Term and Conditional Survival After Esophagectomy Using Random Survival Forests.
    Ann Surg. 2023;277:267-274.
    >> Share

  33. GUO X, Wang Z, Yang H, Mao T, et al
    Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2023;277:259-266.
    >> Share

    January 2023
  34. GRAY KD, Nobel TB, Hsu M, Tan KS, et al
    Improved Preoperative Risk Assessment Tools Are Needed to Guide Informed Decision Making before Esophagectomy.
    Ann Surg. 2023;277:116-120.
    >> Share

    December 2022
  35. ZHANG Y, Dong D, Cao Y, Huang M, et al
    Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Meta-analysis.
    Ann Surg. 2022 Dec 20. doi: 10.1097/SLA.0000000000005782.
    >> Share

  36. CARBONI F, Valle M
    Comment on: "Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short-And Long-term Outcomes From the Dutch Upper GI Cancer Audit".
    Ann Surg. 2022;276:e1121.
    >> Share

  37. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Lindblad M, et al
    Long-term Survival in Esophageal Cancer After Minimally Invasive Esophagectomy Compared to Open Esophagectomy.
    Ann Surg. 2022;276:e744-e748.
    >> Share

  38. KALFF MC, Fransen LFC, de Groot EM, Gisbertz SS, et al
    Long-term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-score Matched Analysis.
    Ann Surg. 2022;276:e749-e757.
    >> Share

  39. SIHAG S, Nobel T, Hsu M, De La Torre S, et al
    Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
    Ann Surg. 2022;276:1017-1022.
    >> Share

  40. JEZERSKYTE E, Mertens AC, Dieren SV, Eshuis WJ, et al
    Gastrectomy Versus Esophagectomy for Gastroesophageal Junction Tumors: Short- and Long-Term Outcomes From the Dutch Upper Gastrointestinal Cancer Audit.
    Ann Surg. 2022;276:e735-e743.
    >> Share

    November 2022
  41. DONLON NE, Moran B, Kamilli A, Davern M, et al
    CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.
    Ann Surg. 2022;276:792-798.
    >> Share

  42. PERA M, Gibert J, Gimeno M, Garsot E, et al
    Machine Learning Risk Prediction Model of 90-day Mortality After Gastrectomy for Cancer.
    Ann Surg. 2022;276:776-783.
    >> Share

  43. COOLS-LARTIGUE J, Markar S, Mueller C, Hofstetter W, et al
    An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:799-805.
    >> Share

  44. WANG S, Huang S, Gao Z, Zhuang W, et al
    Comment on: The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-Negative Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:e645.
    >> Share

  45. OKAMURA A, Yamamoto H, Watanabe M, Miyata H, et al
    Association Between Preoperative HbA1c Levels and Complications after Esophagectomy: Analysis of 15,801 Esophagectomies From the National Clinical Database in Japan.
    Ann Surg. 2022;276:e393-e399.
    >> Share

  46. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia After Esophageal Cancer Surgery: A Spectrum of Lung Injury Rather Than a Simple Infective Complication?
    Ann Surg. 2022;276:e400-e406.
    >> Share

  47. KINGMA BF, Grimminger PP, van der Sluis PC, van Det MJ, et al
    Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE): Results From the Multicenter International Registry.
    Ann Surg. 2022;276:e386-e392.
    >> Share

    October 2022
  48. MATSUDA S, Kitagawa Y, Okui J, Okamura A, et al
    Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 Oct 29. doi: 10.1097/SLA.0000000000005701.
    >> Share

  49. KANDIL E, Omar M, Aboueisha M, Attia AS, et al
    Efficacy and Safety of Radiofrequency Ablation of Thyroid Nodules: A Multi-institutional Prospective Cohort Study.
    Ann Surg. 2022;276:589-596.
    >> Share

    August 2022
  50. RHODIN KE, Raman V, Jensen CW, Kang L, et al
    The Effect of Center Esophagectomy Volume on Outcomes in Clinical Stage I-III Esophageal Cancer.
    Ann Surg. 2022 Aug 30. pii: 00000658-990000000-00247.
    >> Share

  51. RAJA S, Rice TW, Lu M, Semple ME, et al
    Adjuvant Therapy after Neoadjuvant Therapy for Esophageal Cancer: Who Needs It?
    Ann Surg. 2022 Aug 23. pii: 00000658-990000000-00237.
    >> Share

  52. CHANDRA R, Reznik SI
    Vacutainers and Primers Over X-Rays and Gamma Rays: The Role of Circulating Tumor DNA in Esophageal Adenocarcinoma Staging and Surveillance: Invited Commentary on "Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Aden
    Ann Surg. 2022;276:e127-e128.
    >> Share

  53. CABALAG CS, Yates M, Corrales MB, Yeh P, et al
    Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:e120-e126.
    >> Share

  54. SIHAG S, Nobel T, Hsu M, Tan KS, et al
    A More Extensive Lymphadenectomy Enhances Survival After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:312-317.
    >> Share

  55. YANES M, Santoni G, Maret-Ouda J, Ness-Jensen E, et al
    Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries.
    Ann Surg. 2022;276:e79-e85.
    >> Share

    July 2022
  56. KALFF MC, Henckens SPG, Voeten DM, Heineman DJ, et al
    Recurrent Disease after Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study.
    Ann Surg. 2022 Jul 26. pii: 00000658-990000000-00187.
    >> Share

  57. WONG IYH, Chung JCY, Zhang RQ, Gao X, et al
    A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) with Lymph Node Status (ypN-category) Results in Better Prognostication than ypTNM Stage Groups after Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00184.
    >> Share

  58. MATSUDA S, Kitagawa Y, Takemura R, Okui J, et al
    Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score matched Analysis From 85 Authorized Institutes for Esophageal Cancer in Japan.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00138.
    >> Share

  59. HIRANO Y, Konishi T, Kaneko H, Itoh H, et al
    Impact of Prophylactic Corticosteroid Use on In-hospital Mortality and Respiratory Failure after Esophagectomy for Esophageal Cancer: Nationwide Inpatient Data Study in Japan.
    Ann Surg. 2022 Jul 14. pii: 00000658-990000000-00106.
    >> Share

  60. JUNTTILA A, Helminen O, Helmio M, Huhta H, et al
    Five-year Survival after McKeown Compared to Ivor-Lewis Esophagectomy for Esophageal Cancer: A Population-based Nationwide Study in Finland.
    Ann Surg. 2022 Jul 12. pii: 00000658-990000000-00103.
    >> Share

  61. ZHANG Y, Cao Y, Zhang J, Huang M, et al
    Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00063.
    >> Share

  62. JOGIAT UM, Sasewich H, Turner SR, Baracos V, et al
    Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00081.
    >> Share

  63. HOSOI T, Abe T, Higaki E, Fujieda H, et al
    Circular Stapled Technique Versus Modified Collard Technique for Cervical Esophagogastric Anastomosis After Esophagectomy: A Randomized Controlled Trial.
    Ann Surg. 2022;276:30-37.
    >> Share

  64. MOTOYAMA S, Maeda E, Iijima K, Sato Y, et al
    Does Esophagectomy Provide a Survival Advantage to Patients Aged 80 Years or Older? Analyzing 5066 Patients in the National Database of Hospital-based Cancer Registries in Japan.
    Ann Surg. 2022;276:e16-e23.
    >> Share

  65. POINTER DT JR, Saeed S, Naffouje SA, Mehta R, et al
    Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis.
    Ann Surg. 2022;276:111-118.
    >> Share

  66. HUGHES DT, Reyes-Gastelum D, Ward KC, Hamilton AS, et al
    Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.
    Ann Surg. 2022;276:e40-e47.
    >> Share

    May 2022
  67. OKUNO K, Tokunaga M, Kinugasa Y, Baba H, et al
    A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 May 13. pii: 00000658-990000000-00001.
    >> Share

  68. CLAASSEN L, Hannink G, Luyer MDP, Ainsworth AP, et al
    Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study.
    Ann Surg. 2022;275:911-918.
    >> Share

  69. FRANSEN LFC, Janssen THJB, Aarnoudse M, Nieuwenhuijzen GAP, et al
    Direct Oral Feeding After a Minimally Invasive Esophagectomy: A Single-Center Prospective Cohort Study.
    Ann Surg. 2022;275:919-923.
    >> Share

    April 2022
  70. SHEN Y, Zhang Y, He M, Fang Y, et al
    Advancing Gastroscope From Intraluminal to Extraluminal Dissection: Primary Experience of Laparo-gastroscopic Esophagectomy.
    Ann Surg. 2022;275:e659-e663.
    >> Share

  71. SUH YS, Na D, Lee JS, Chae J, et al
    Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
    Ann Surg. 2022;275:706-717.
    >> Share

  72. KAMARAJAH SK, Phillips AW, Hanna GB, Low DE, et al
    Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma?: A Propensity-matched Analysis.
    Ann Surg. 2022;275:700-705.
    >> Share

    March 2022
  73. KUPPUSAMY MK, Low DE
    Evaluation of International Contemporary Operative Outcomes and Management Trends Associated With Esophagectomy: A 4-Year Study of >6000 Patients Using ECCG Definitions and the Online Esodata Database.
    Ann Surg. 2022;275:515-525.
    >> Share

  74. RAMAN V, Jawitz OK, Farrow NE, Voigt SL, et al
    The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.
    Ann Surg. 2022;275:e562-e567.
    >> Share

    February 2022
  75. LI S, Ai Q, Liang H, Liu H, et al
    Nonintubated Robotic-assisted Thoracic Surgery for Tracheal/Airway Resection and Reconstruction: Technique Description and Preliminary Results.
    Ann Surg. 2022;275:e534-e536.
    >> Share

  76. MARKAR SR, Zaninotto G, Castoro C, Johar A, et al
    Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study.
    Ann Surg. 2022;275:e392-e400.
    >> Share

  77. RUCKER AJ, Raman V, Jawitz OK, Voigt SL, et al
    The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.
    Ann Surg. 2022;275:348-355.
    >> Share

    January 2022
  78. ELLIOTT JA, Markar SR, Klevebro F, Johar A, et al
    An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE).
    Ann Surg. 2022 Jan 27. pii: 00000658-900000000-93088.
    >> Share

  79. SANABRIA A, Betancourt C, Sanchez JG, Garcia C, et al
    Prophylactic Central Neck Lymph Node Dissection in Low-Risk Thyroid Carcinoma Patients Does not Decrease the Incidence of Locoregional Recurrence: A Meta-Analysis of Randomized Trials.
    Ann Surg. 2022 Jan 24. pii: 00000658-900000000-93112.
    >> Share

  80. BOSHIER PR, Klevebro F, Savva KV, Waller A, et al
    Assessment of Health Related Quality of Life and Digestive Symptoms in Long-term, Disease Free Survivors After Esophagectomy.
    Ann Surg. 2022;275:e140-e147.
    >> Share

  81. HARRIS A, Butterworth J, Boshier PR, MacKenzie H, et al
    Development of a Reliable Surgical Quality Assurance System for 2-stage Esophagectomy in Randomized Controlled Trials.
    Ann Surg. 2022;275:121-130.
    >> Share

    December 2021
  82. OSHIKIRI T, Numasaki H, Oguma J, Toh Y, et al
    Prognosis of Patients with Esophageal Carcinoma following Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93155.
    >> Share

  83. CLAASSEN L, Hannink G, van Workum F, Rosman C, et al
    Response to the Comment on "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics a Retrospective Multi-national Cohort Study".
    Ann Surg. 2021;274:e930.
    >> Share

  84. PRASAD P, Phillips AW
    Comment on "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study".
    Ann Surg. 2021;274:e929-e930.
    >> Share

  85. HOLSCHER AH, Bollschweiler E
    Comment on "Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma? A Propensity-matched Analysis".
    Ann Surg. 2021;274:e916-e917.
    >> Share

  86. NABHAN FA
    Comment on "Barriers to the Use of Active Surveillance for Thyroid Cancer: Results of a Physicians Survey".
    Ann Surg. 2021;274:e880-e881.
    >> Share

  87. SHEN H, Liu Q
    Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e805-e806.
    >> Share

  88. LU J, Wu D, Huang C
    Comment on "The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e845-e846.
    >> Share

  89. RAJA S, Blackstone EH
    Response to the Comments on "Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e757-e758.
    >> Share

  90. KUROKAWA Y, Doki Y, Takeuchi H, Kitagawa Y, et al
    Response to the Comment on: Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors.
    Ann Surg. 2021;274:e806-e807.
    >> Share

  91. FRANSEN LFC, Luyer MDP
    Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e741-e742.
    >> Share

  92. ZHANG G, Zhang H, Li Q, Li J, et al
    Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e740-e741.
    >> Share

  93. KHAW RA, Kamarajah SK, Phillips AW
    Comments on "Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e756-e757.
    >> Share

  94. MORIS D, Tsilimigras DI, Schizas D
    Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e744-e745.
    >> Share

  95. FRANSEN LFC, Luyer MDP
    Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e745-e746.
    >> Share

  96. KUROKAWA Y, Takeuchi H, Doki Y, Kitagawa Y, et al
    Response to the Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e682-e683.
    >> Share

  97. ZHAO B, Liang R, Li G
    Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e681-e682.
    >> Share

  98. VAN DER WILK BJ, van Lanschot JJB
    Response to the Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2021;274:e697-e698.
    >> Share

  99. GUTSCHOW CA
    Response to the Comment on "Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database".
    Ann Surg. 2021;274:e686.
    >> Share

  100. MOLENA D, Louie BE, Demeester SR
    Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2021;274:e695-e696.
    >> Share

  101. KAMARAJAH SK, Griffiths EA
    Comment on "Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database".
    Ann Surg. 2021;274:e685-e686.
    >> Share

  102. YONEKURA H, Nakamori Y, Takeda C, Kawasaki Y, et al
    Comment on "The Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2021;274:e672.
    >> Share

  103. FRANSEN LFC, Berkelmans GHK, Asti E, Henegouwen MIVB, et al
    The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study.
    Ann Surg. 2021;274:e1129-e1137.
    >> Share

  104. SAKAMOTO T, Fujiogi M, Yasunaga H
    Response to the Comment on "Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2021;274:e672-e673.
    >> Share

  105. LENG X, He W, Yang H, Chen Y, et al
    Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2021;274:e1022-e1029.
    >> Share

  106. MARET-OUDA J, Santoni G, Wahlin K, Artama M, et al
    Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
    Ann Surg. 2021;274:e535-e540.
    >> Share

  107. SCHOPPMANN SF, Jomrich G
    Response to the Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Ann Surg. 2021;274:e669-e670.
    >> Share

  108. SUN L, Liang H, Feng Y
    Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Ann Surg. 2021;274:e668-e669.
    >> Share

  109. VAN DER WILK BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, et al
    Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
    Ann Surg. 2021;274:1009-1016.
    >> Share

    November 2021
  110. HIRANO Y, Kaneko H, Konishi T, Itoh H, et al
    Impact of Body Mass Index on Major Complications, Multiple Complications, In-hospital Mortality, and Failure to Rescue Following Esophagectomy for Esophageal Cancer: A Nationwide Inpatient Database Study in Japan.
    Ann Surg. 2021 Nov 23. pii: 00000658-900000000-93169.
    >> Share

  111. LIU F, Yang W, Yang W, Xu R, et al
    Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer from a Real-World Multicenter Study.
    Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93196.
    >> Share

  112. HE Z, Liu F, Yang W, Ke Y, et al
    Response to: Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".
    Ann Surg. 2021 Nov 9. pii: 00000658-900000000-93201.
    >> Share

  113. HUANG S, Wang S, Gao Z, Qiao G, et al
    Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".
    Ann Surg. 2021 Nov 9. pii: 00000658-900000000-93198.
    >> Share

  114. KALFF MC, Gottlieb-Vedi E, Verhoeven RHA, van Laarhoven HWM, et al
    Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands.
    Ann Surg. 2021;274:743-750.
    >> Share

  115. HERTAULT H, Gandon A, Behal H, Legault G, et al
    Incidence and Risk Factors for Diaphragmatic Herniation Following Esophagectomy for Cancer.
    Ann Surg. 2021;274:758-765.
    >> Share

  116. MULLER PC, Morell B, Vetter D, Raptis DA, et al
    Preemptive Endoluminal Vacuum Therapy to Reduce Morbidity After Minimally Invasive Ivor Lewis Esophagectomy: Including a Novel Grading System for Postoperative Endoscopic Assessment of GI-Anastomoses.
    Ann Surg. 2021;274:751-757.
    >> Share

  117. DONLON NE, Kammili A, Roopnarinesingh R, Davern M, et al
    FLOT-regimen Chemotherapy and Transthoracic en bloc Resection for Esophageal and Junctional Adenocarcinoma.
    Ann Surg. 2021;274:814-820.
    >> Share

  118. WONG IYH, Zhang RQ, Tsang RKY, Kwok JYY, et al
    Improving Outcome of Superior Mediastinal Lymph Node Dissection During Esophagectomy: A Novel Approach Combining Continuous and Intermittent Recurrent Laryngeal Nerve Monitoring.
    Ann Surg. 2021;274:736-742.
    >> Share

    October 2021
  119. RAJA S, Rice TW, Murthy SC, Ahmad U, et al
    Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma.
    Ann Surg. 2021;274:e320-e327.
    >> Share

    September 2021
  120. LEE Y, Samarasinghe Y, Lee MH, Thiru L, et al
    Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis.
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93257.
    >> Share

  121. KLOFT M, Ruisch JE, Raghuram G, Emmerson J, et al
    Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial.
    Ann Surg. 2021 Sep 13. pii: 00000658-900000000-93281.
    >> Share

  122. VOETEN DM, Gisbertz SS, Ruurda JP, Wilschut JA, et al
    Overall Volume Trends in Esophageal Cancer Surgery Results From the Dutch Upper Gastrointestinal Cancer Audit.
    Ann Surg. 2021;274:449-458.
    >> Share

  123. KAMEL MK, Harrison S, Lee B, Port JL, et al
    Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity Matched Analysis of the National Cancer Database.
    Ann Surg. 2021 Sep 1. pii: 00000658-900000000-93285.
    >> Share

  124. LIMBERG J, Ullmann TM, Stefanova D, Buicko JL, et al
    Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer?: A National Cancer Database Analysis.
    Ann Surg. 2021;274:e276-e281.
    >> Share

  125. CLARK JM, Cooke DT, Hashimi H, Chin D, et al
    Do the 2018 Leapfrog Group Minimal Hospital and Surgeon Volume Thresholds for Esophagectomy Favor Specific Patient Demographics?
    Ann Surg. 2021;274:e220-e229.
    >> Share

    August 2021
  126. FRANSEN LFC, Luyer MDP
    Response to the Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial) an International, Multicenter, Open-label Randomized Controlled Trial".
    Ann Surg. 2021;274:e196-e197.
    >> Share

  127. MORIS D, Cerullo M
    Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial".
    Ann Surg. 2021;274:e196.
    >> Share

  128. SAKAMOTO T, Fujiogi M, Matsui H, Fushimi K, et al
    Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis.
    Ann Surg. 2021;274:324-330.
    >> Share

    July 2021
  129. NOMA T, Makino T, Ohshima K, Sugimura K, et al
    Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93382.
    >> Share

  130. DEFIZE IL, Goense L, Borggreve AS, Mook S, et al
    Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results from the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93365.
    >> Share

  131. VOETEN DM, Busweiler LAD, van der Werf LR, Wijnhoven BPL, et al
    Outcomes of Esophagogastric Cancer Surgery during eight Years of Surgical Auditing by the Dutch Upper Gastrointestinal Cancer Audit (DUCA).
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93364.
    >> Share

  132. DEMEESTER SR
    Response to the Comment on "The Prevalence of Lymph Node Metastases in Patients With T1 Esophageal Adenocarcinoma A Retrospective Review of Esophagectomy Specimens".
    Ann Surg. 2021;274:e106-e107.
    >> Share

  133. KUROKAWA Y, Takeuchi H, Doki Y, Mine S, et al
    Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
    Ann Surg. 2021;274:120-127.
    >> Share

    June 2021
  134. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Hedberg J, et al
    Extent of Lymphadenectomy and Long-Term Survival in Esophageal Cancer.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93462.
    >> Share

  135. YANG Y, Li B, Yi J, Hua R, et al
    Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial.
    Ann Surg. 2021 Jun 18. pii: 00000658-900000000-93478.
    >> Share

  136. WANG BY, Lin CH, Wu SC, Chen HS, et al
    Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2021 Jun 10. pii: 00000658-900000000-93505.
    >> Share

  137. YANG W, Liu F, Xu R, Yang W, et al
    Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data.
    Ann Surg. 2021 Jun 2. pii: 00000658-900000000-93529.
    >> Share

  138. KELLY RJ, Ansari AM, Miyashita T, Zahurak M, et al
    Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
    Ann Surg. 2021;273:e206-e213.
    >> Share

    May 2021
  139. DU J, Shen X
    Comment on "Genomic Alteration and Immunity-Implications In Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93540.
    >> Share

  140. DU J, Guan W, Shen X
    Comment on "Circulating Tumor Cells-New Indicator For Clinical Staging Of Patients With Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93536.
    >> Share

  141. KOSUMI K, Baba Y, Baba H
    Response to Comment on "Genomic Alteration and Immunity-Implications in Esophageal Cancer".
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93548.
    >> Share

  142. REEH M
    Response to Comment on "Circulating Tumor Cells - New Indicator for Clinical Staging of Patients with Esophageal Cancer" by Wenxian Guan.
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93547.
    >> Share

  143. VAN DER WILK BJ, Eyck BM, Hofstetter WL, Ajani JA, et al
    Chemoradiotherapy followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis.
    Ann Surg. 2021 May 11. doi: 10.1097/SLA.0000000000004930.
    >> Share

  144. XIE SH, Santoni G, Malberg K, Lagergren P, et al
    Prediction Model of Long-term Survival After Esophageal Cancer Surgery.
    Ann Surg. 2021;273:933-939.
    >> Share

    April 2021
  145. HARADA K, Hwang H, Wang X, Abdelhakeem A, et al
    Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.
    Ann Surg. 2021;273:751-757.
    >> Share

  146. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a Simple Infective Complication? (ANNSURG-D21-00007).
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004873.
    >> Share

  147. BABA Y, Kosumi K, Baba H
    Comments on "The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?"
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004879.
    >> Share

    March 2021
  148. LEVY J, Gupta V, Coburn NG
    Response to "Comment on Textbook Outcome and Survival in Patients with Gastric Cancer: An Analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO)".
    Ann Surg. 2021 Mar 5. pii: 00000658-900000000-93662.
    >> Share

  149. JAWITZ NG, Raman V, Jawitz OK, Shimpi RA, et al
    Utilization Trends and Volume-Outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer.
    Ann Surg. 2021 Mar 3. doi: 10.1097/SLA.0000000000004834.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016